
Tenet Healthcare (THC) is highlighted as a compelling value stock, holding a Zacks Rank #2 (Buy) and a VGM Score of A. The company's attractiveness is further supported by a Value Style Score of A, driven by a forward P/E ratio of 13.01, and a 26.4% average earnings surprise; nine analysts have increased their fiscal year 2025 earnings estimates in the last two months, raising the consensus to $12.69 per share.
Tenet Healthcare (THC) is identified as a strong candidate for value-oriented investors, supported by a Zacks Rank #2 (Buy) and a top-tier VGM Score of A. The company's favorable valuation metrics are underscored by a Value Style Score of A, with a forward Price-to-Earnings (P/E) ratio of 13.01. This suggests the stock may be undervalued relative to its earnings potential. Further strengthening the investment thesis, nine analysts have revised their earnings estimates upward for fiscal year 2025 within the last 60 days, resulting in the Zacks Consensus Estimate increasing by $0.54 to $12.69 per share. Additionally, Tenet Healthcare has a notable history of outperforming market expectations, boasting an average earnings surprise of 26.4%. The combination of these factors—a strong Zacks Rank, favorable Style Scores, positive earnings estimate revisions, and a consistent earnings beat—indicates a potentially robust outlook for the company.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment